Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GMP Violations Are A Consistent But Well-Shuffled Deck, FDA Data Show

Executive Summary

The same five sets of cGMP violations have shown up for at least the past five fiscal years when FDA inspects drug manufacturers, according to a database the agency recently made public.

You may also be interested in...

Industry Compliance Data Should Be Linked To Enforcement Results, FDA Transparency Taskforce Says

FDA's website should resemble EPA's and Department of Labor's, report concludes.

In Brief

CDER reorganizes for global compliance

In Brief

CDER reorganizes for global compliance





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts